Behçet's disease and familial Mediterranean fever: Two sides of the same coin or just an association? A cross-sectional study
- PMID: 27776949
- DOI: 10.1016/j.ejim.2016.10.011
Behçet's disease and familial Mediterranean fever: Two sides of the same coin or just an association? A cross-sectional study
Abstract
Background: Familial Mediterranean fever (FMF) is a genetic disease, characterized by attacks of fever, arthritis, serositis and pain. Behçet's disease (BD) is an inflammatory disorder with a genetic basis, characterized by oral and genital ulcers, uveitis, pustular erythematous cutaneous lesions, arthritis, central nervous system involvement and possible vascular manifestations such as venous thrombosis, arteritis and aneurysms.
Objectives: To investigate the association and actual differentiation between these two entities in a large-scale population-based study.
Methods: Data for this study was collected from the databases of "Clalit Health Services", the largest state-mandated health service organization in Israel. All adult members diagnosed with BD were included (n=892) and as well as their age- and sex-matched controls (n=4444), creating a cross-sectional population-based study. Medical records of all subjects were analyzed for documented FMF. A logistic regression model was done to estimate how BD, age, gender, BMI, ethnicity and socioeconomic status contributed as risk factors for FMF.
Results: The proportion of FMF in patients with BD increased compared with those reported in controls (5.83% and 0.23%, respectively, P<0.001). This coexistence was prominent among both sex groups but was much stronger among female BD patients (females with OR of 177 and of 8.4 in males, P<0.001). In a multivariate analysis, BD was identified as an independent risk factor for FMF (OR 25.16, 95% CI 13-53.3).
Conclusion: BD diagnosis was found to be independently associated with higher incidence of FMF, especially in females, people of Arab descent and BMI>30. Our data imply that understating the differentiation between FMF and BD is not evident and clear in a real-life population of patients with BD.
Keywords: Behçet's disease; Comorbidity; FMF; Fever; MEFV gene.
Copyright © 2016 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Familial mediterranean fever and Behçet's disease--are they associated?J Rheumatol. 2002 Mar;29(3):530-4. J Rheumatol. 2002. PMID: 11908568
-
MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement.Clin Exp Rheumatol. 2003 Jul-Aug;21(4 Suppl 30):S35-7. Clin Exp Rheumatol. 2003. PMID: 14727457
-
MEFV, TNFRSF1A and CARD15 mutation analysis in Behçet's disease.Clin Exp Rheumatol. 2011 Jul-Aug;29(4 Suppl 67):S24-7. Epub 2011 Sep 27. Clin Exp Rheumatol. 2011. PMID: 21385537
-
Behçet disease, familial Mediterranean fever and MEFV variations: More than just an association.Clin Immunol. 2023 Jun;251:109630. doi: 10.1016/j.clim.2023.109630. Epub 2023 Apr 30. Clin Immunol. 2023. PMID: 37216220 Review.
-
[Familial Mediterranean Fever (FMF): from diagnosis to treatment].Sante. 2004 Oct-Dec;14(4):261-6. Sante. 2004. PMID: 15745878 Review. French.
Cited by
-
Associated diseases and their effects on disease course in patients with chronic non-bacterial osteomyelitis: retrospective experience from a single center.Clin Rheumatol. 2025 Feb;44(2):855-862. doi: 10.1007/s10067-025-07306-1. Epub 2025 Jan 14. Clin Rheumatol. 2025. PMID: 39808231 Free PMC article.
-
Possible Association of Mutations in the MEFV Gene with the Intestinal Phenotype of Behçet's Disease and Refractoriness to Treatment.J Clin Med. 2023 Apr 26;12(9):3131. doi: 10.3390/jcm12093131. J Clin Med. 2023. PMID: 37176572 Free PMC article.
-
Vertebral artery dissection associated with familial Mediterranean fever and Behçet's disease.Ann Clin Transl Neurol. 2019 Apr 4;6(5):974-978. doi: 10.1002/acn3.773. eCollection 2019 May. Ann Clin Transl Neurol. 2019. PMID: 31139696 Free PMC article.
-
Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival.Oncoimmunology. 2019 Mar 24;8(6):e1588084. doi: 10.1080/2162402X.2019.1588084. eCollection 2019. Oncoimmunology. 2019. PMID: 31069155 Free PMC article.
-
Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review.Front Immunol. 2021 Nov 11;12:744780. doi: 10.3389/fimmu.2021.744780. eCollection 2021. Front Immunol. 2021. PMID: 34858402 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical